A CRISPR-del-based pipeline for complete gene knockout in human diploid cells

Author:

Komori Takuma1,Hata Shoji12ORCID,Mabuchi Akira1,Genova Mariya3,Harada Tomoki1,Fukuyama Masamitsu1,Chinen Takumi1,Kitagawa Daiju1ORCID

Affiliation:

1. Graduate School of Pharmaceutical Sciences, The University of Tokyo 1 Department of Physiological Chemistry , , Bunkyo, 113-0033 Tokyo , Japan

2. Precursory Research for Embryonic Science and Technology (PRESTO) Program, Japan Science and Technology Agency 2 , Honcho Kawaguchi, 102-8666 Saitama , Japan

3. Zentrum für Molekulare Biologie, Universität Heidelberg, DKFZ-ZMBH Allianz 3 , 69120 Heidelberg , Germany

Abstract

ABSTRACT The advance of CRISPR/Cas9 technology has enabled us easily to generate gene knockout cell lines by introducing insertion–deletion mutations (indels) at the target site via the error-prone non-homologous end joining repair system. Frameshift-promoting indels can disrupt gene functions by generation of a premature stop codon. However, there is growing evidence that targeted genes are not always knocked out by the indel-based gene disruption. Here, we established a pipeline of CRISPR-del, which induces a large chromosomal deletion by cutting two different target sites, to perform ‘complete’ gene knockout efficiently in human diploid cells. Quantitative analyses show that the frequency of gene deletion with this approach is much higher than that of conventional CRISPR-del methods. The lengths of the deleted genomic regions demonstrated in this study are longer than those of 95% of the human protein-coding genes. Furthermore, the pipeline enabled the generation of a model cell line having a bi-allelic cancer-associated chromosomal deletion. Overall, these data lead us to propose that the CRISPR-del pipeline is an efficient and practical approach for producing ‘complete’ gene knockout cell lines in human diploid cells.

Funder

Japan Society for the Promotion of Science

Japan Science and Technology Agency

Takeda Science Foundation

Uehara Memorial Foundation

Research Foundation for Pharmaceutical Sciences, Koyanagi Foundatio

Kanae Foundation for the Promotion of Medical Science

Kato Memorial Bioscience Foundation

Tokyo Foundation for Pharmaceutical Sciences

Naito Foundation

Mochida Memorial Foundation for Medical and Pharmaceutical Research

Sumitomo Foundation

University of Tokyo

Publisher

The Company of Biologists

Subject

Cell Biology

Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3